Clinical Trials Browser

Phase 2 × INDUSTRY × fludarabine phosphate × Clear all

NCT06500273 2026-06-02

ALPHA3

Phase 2 Recruiting

Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual

NCT04268706 2023-04-05

Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)

Phase 2 Active not recruiting

Hodgkin Disease

NCT01690520 2021-07-06

Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

Phase 2 Completed

163 enrolled 19 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00875667 2019-09-16

Sprint

Phase 2 Completed

254 enrolled 59 charts

Lymphoma, Lymphoma, Mantle-Cell

NCT01175785 2019-03-05

Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies

Phase 2 Completed

Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

NCT00185445 2013-12-04

Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL

Phase 2 Completed

Lymphoma, Non-Hodgkin

NCT00311129 2013-12-04

Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL

Phase 2 Completed

Lymphoma, Non-Hodgkin

NCT00688883 2013-12-04

Fludara (Oral) Phase II Study for Indolent Lymphoma

Phase 2 Completed

Lymphoma